Skip to main content
PMC home page
Gut logoLink to Gut
. 1971 Apr;12(4):324–329. doi: 10.1136/gut.12.4.324

Halothane hepatitis.

S Sherlock
PMCID: PMC1411625  PMID: 4930157

Full text

PDF
325

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biebuyck J. F., Saunders S. J., Harrison G. G., Bull A. B. Multiple halothane exposure and hepatic bromsulphthalein clearance. Br Med J. 1970 Mar 14;1(5697):668–671. doi: 10.1136/bmj.1.5697.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Combes B. Halothane-induced liver damage--an entity. N Engl J Med. 1969 Mar 6;280(10):558–559. doi: 10.1056/NEJM196903062801010. [DOI] [PubMed] [Google Scholar]
  3. Davidson C. S., Babior B., Popper H. Concerning hepatotoxicity of halothane. N Engl J Med. 1966 Dec 29;275(26):1497–1497. doi: 10.1056/NEJM196612292752609. [DOI] [PubMed] [Google Scholar]
  4. Doniach D., Roitt I. M., Walker J. G., Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966 Jul;1(3):237–262. [PMC free article] [PubMed] [Google Scholar]
  5. Fox R. A., Niazi S. P., Sherlock S. Hepatitis-associated antigen in chronic liver disease. Lancet. 1969 Sep 20;2(7621):609–612. doi: 10.1016/s0140-6736(69)90324-9. [DOI] [PubMed] [Google Scholar]
  6. Hughes M., Powell L. W. Recurrent hepatitis in patients receiving multiple halothane anesthetics for radium treatment of carcinoma of the cervix uteri. Gastroenterology. 1970 Jun;58(6):790–797. [PubMed] [Google Scholar]
  7. KEERI SZANTO M., LAFLEUR F. POSTANESTHETIC LIVER COMPLICATIONS IN A GENERAL HOSPITAL: A STATISTICAL STUDY. Can Anaesth Soc J. 1963 Nov;10:531–538. doi: 10.1007/BF03002086. [DOI] [PubMed] [Google Scholar]
  8. Katz S. Hepatic coma associated with methoxyflurane anesthesia. Report of a case. Am J Dig Dis. 1970 Aug;15(8):733–739. doi: 10.1007/BF02235995. [DOI] [PubMed] [Google Scholar]
  9. Klatskin G., Kimberg D. V. Recurrent hepatitis attributable to halothane sensitization in an anesthetist. N Engl J Med. 1969 Mar 6;280(10):515–522. doi: 10.1056/NEJM196903062801001. [DOI] [PubMed] [Google Scholar]
  10. Klein N. C., Jeffries G. H. Hepatotoxicity after methoxyflurane administration. JAMA. 1966 Sep 19;197(12):1037–1039. [PubMed] [Google Scholar]
  11. Klion F. M., Schaffner F., Popper H. Hepatitis after exposure to halothane. Ann Intern Med. 1969 Sep;71(3):467–477. doi: 10.7326/0003-4819-71-3-467. [DOI] [PubMed] [Google Scholar]
  12. MUSHIN W. W., ROSEN M., BOWEN D. J., CAMPBELL H. HALOTHANE AND LIVER DYSFUNCTION: A RETROSPECTIVE STUDY. Br Med J. 1964 Aug 8;2(5405):329–341. doi: 10.1136/bmj.2.5405.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ohen E. H. Metabolism of halothane. Anesthesiology. 1967 Jul-Aug;28(4):651–651. [PubMed] [Google Scholar]
  14. POPPER H., SCHAFFNER F. FINE STRUCTURAL CHANGES OF THE LIVER. Ann Intern Med. 1963 Nov;59:674–691. doi: 10.7326/0003-4819-59-5-674. [DOI] [PubMed] [Google Scholar]
  15. Paronetto F., Popper H. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N Engl J Med. 1970 Aug 6;283(6):277–280. doi: 10.1056/NEJM197008062830602. [DOI] [PubMed] [Google Scholar]
  16. Peters R. L., Edmondson H. A., Reynolds T. B., Meister J. C., Curpey T. J. Hepatic necrosis associated with halothane anesthesia. Am J Med. 1969 Nov;47(5):748–764. doi: 10.1016/0002-9343(69)90168-5. [DOI] [PubMed] [Google Scholar]
  17. Rodriguez M., Paronetto F., Schaffner F., Popper H. Antimitochondrial antibodies in jaundice following drug administration. JAMA. 1969 Apr 7;208(1):148–150. [PubMed] [Google Scholar]
  18. SCHMID M., HEFTI M. L., GATTIKER R., KISTLER H. J., SENNING A. BENIGN POSTOPERATIVE INTRAHEPATIC CHOLESTASIS. N Engl J Med. 1965 Mar 18;272:545–550. doi: 10.1056/NEJM196503182721101. [DOI] [PubMed] [Google Scholar]
  19. SHERLOCK S. HALOTHANE AND THE LIVER. Proc R Soc Med. 1964 Apr;57:305–307. [PMC free article] [PubMed] [Google Scholar]
  20. SLATER E. M., GIBSON J. M., DYKES M. H., WALZER S. G. POSTOPERATIVE HEPATIC NECROSIS. ITS INCIDENCE AND DIAGNOSTIC VALUE IN ASSOCIATION WITH THE ADMINISTRATION OF HALOTHANE. N Engl J Med. 1964 May 7;270:983–987. doi: 10.1056/NEJM196405072701904. [DOI] [PubMed] [Google Scholar]
  21. Stefanini M., Herland A., Kosyak E. P. Fatal massive necrosis of the liver after repeated exposure to methoxyflurane. Anesthesiology. 1970 Apr;32(4):374–378. doi: 10.1097/00000542-197004000-00019. [DOI] [PubMed] [Google Scholar]
  22. Trey C., Lipworth L., Chalmers T. C., Davidson C. S., Gottlieb L. S., Popper H., Saunders S. J. Fulminant hepatic failure. Presumable contribution to halothane. N Engl J Med. 1968 Oct 10;279(15):798–801. doi: 10.1056/NEJM196810102791504. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES